NOD1 and obesity disorder: NOD1 has been implicated in chronic inflammatory conditions and metabolic disorders, including insulin resistance and obesity‐related inflammation (Ait Yahia et al., 2021; Rodrigues E‐Lacerda et al., 2023; Schertzer et al., 2011).